- Home
- CYTO
as 07-26-2024 4:00pm EST
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.
| Founded: | 2003 | Country: | Bermuda |
| Employees: | N/A | City: | N/A |
| Market Cap: | 2.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 294.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.00 - $17.20 | Next Earning Date: | 09-10-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Altamira Therapeutics Ltd. News
CYTO Breaking Stock News: Dive into CYTO Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
GlobeNewswire
a month ago
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
Business Wire
2 months ago
Net Asset Value(s)
Business Wire
2 months ago
MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence
Business Wire
2 months ago
Entrust Enables Governments to Transform Citizen Interactions with Digital Identities
PR Newswire
2 months ago
Dstny honored with 'Employee Wellbeing Award'
Newsfile
2 months ago
RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon
PR Newswire
2 months ago
Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024
Compare CYTO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYTO Altamira Therapeutics Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.